Jack Wang
Chief Executive Officer at Winhealth Pharma Group Co. Ltd.
Jack Wang active positions
| Companies | Position | Start | End |
|---|---|---|---|
Winhealth Pharma Group Co. Ltd.
 Winhealth Pharma Group Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Winhealth Pharma Group Co. Ltd. is a Chinese innovative biomedical company founded in 2006, providing novel breakthrough therapies to patients with rare diseases and other unmet medical needs. The company is based in Hangzhou, China. Winhealth Pharma Group has established long-term strategic partnerships with dozens of world-leading biotechnology companies, including Roche, Pfizer, Kyowa Kirin, Shionogi, Cumberland Pharmaceutical, and Daiichi-Sankyo. It has built a unique, balanced, and diversified portfolio with numerous orphan drugs and specialty products at commercial and late clinical stages, and will continuously look to bring in more innovative therapies from the globe. The company was founded in 2006 by Cherry Hu and Jack Wang. Jack Wang has been the CEO since 2006. | Chief Executive Officer | 01/01/2006 | - |
| Chairman | 01/01/2006 | - | |
| Founder | 01/01/2006 | - |
Career history of Jack Wang
Statistics
International
| China | 2 |
Operational
| Chief Executive Officer | 1 |
| Chairman | 1 |
| Founder | 1 |
Sectoral
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Winhealth Pharma Group Co. Ltd.
Winhealth Pharma Group Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Winhealth Pharma Group Co. Ltd. is a Chinese innovative biomedical company founded in 2006, providing novel breakthrough therapies to patients with rare diseases and other unmet medical needs. The company is based in Hangzhou, China. Winhealth Pharma Group has established long-term strategic partnerships with dozens of world-leading biotechnology companies, including Roche, Pfizer, Kyowa Kirin, Shionogi, Cumberland Pharmaceutical, and Daiichi-Sankyo. It has built a unique, balanced, and diversified portfolio with numerous orphan drugs and specialty products at commercial and late clinical stages, and will continuously look to bring in more innovative therapies from the globe. The company was founded in 2006 by Cherry Hu and Jack Wang. Jack Wang has been the CEO since 2006. | Commercial Services |
- Stock Market
- Insiders
- Jack Wang
- Experience
